Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae

Journal of Biotechnology

Volumn 150, Issue 1, 2010, Pages 31-36

  Kim, Hyoung Jin ^a   Lee, Seung Jae ^a   Kim, Hong Jin ^a  

^a Chung Ang University   (South Korea)

Author keywords

Cervical cancer; Human papillomavirus; MRNA secondary structure; Saccharomyces cerevisiae; Virus like particles

Indexed keywords

CERVICAL CANCERS; HUMAN PAPILLOMAVIRUS; MRNA SECONDARY STRUCTURE; SACCHAROMYCES CEREVISIAE; VIRUS-LIKE PARTICLES;

ONCOGENIC VIRUSES; OPTIMIZATION; RNA; TRANSCRIPTION;

YEAST;

CAPSID PROTEIN L1; MESSENGER RNA; WART VIRUS VACCINE;

ARTICLE; CODON; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RNA STRUCTURE; SACCHAROMYCES CEREVISIAE; UTERINE CERVIX CANCER; VIRION; VIRUS GENE; VIRUS LIKE AGENT; WILD TYPE;

BASE SEQUENCE; BLOTTING, WESTERN; CAPSID PROTEINS; CODON; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMAN PAPILLOMAVIRUS 16; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; ONCOGENE PROTEINS, VIRAL; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, VIRAL; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE; SACCHAROMYCES CEREVISIAE;

EID: 77957357536     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2010.07.032     Document Type: Article

References (32)

1. Baker T.S., Newcomb W.W., Olson N.H., Cowsert L.M., Olson C., Brown J.C. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 1991, 60:1445-1456.
2. Bernstein J.A., Khodursky A.B., Lin P.H., Lin-Chao S., Cohen S.N. Global analysis of mRNA decay and abundance in Escherichia coli at single-gene resolution using two-color fluorescent DNA microarrays. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:9697-9702.
3. Biemelt S., Sonnewald U., Galmbacher P., Willmitzer L., Muller M. Production of human papillomavirus type 16 virus-like particles in transgenic plants. J. Virol. 2003, 77:9211-9220.
4. Burgess-Brown N.A., Sharma S., Sobott F., Loenarz C., Oppermann U., Gileadi O. Codon optimization can improve expression of human genes in Escherichia coli: a multi-gene study. Protein Expr. Purif. 2008, 59:94-102.
5. Cook J.C., Joyce J.G., George H.A., Schultz L.D., Hurni W.M., Jansen K.U., Hepler R.W., Ip C., Lowe R.S., Keller P.M., Lehman E.D. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae. Protein Expr. Purif. 1999, 17:477-484.
6. Gu W., Zhou T., Wilke C.O. A universal trend of reduced mRNA stability near the translation-initiation site in prokaryotes and eukaryotes. PLoS Comput. Biol. 2010, 6:e1000664.
7. Han J.H., Choi Y.S., Kim W.J., Jeon Y.H., Lee S.K., Lee B.J., Ryu K.S. Codon optimization enhances protein expression of human peptide deformylase in E. coli. Protein Expr. Purif. 2010, 70:224-230.
8. Jeong N.H., Lee N.W., Woo M.K., Kim H.J. Serologic response to human papillomavirus type 16 virus-like particles in Korean women with cervical precancerous and cancerous lesions. Arch. Pharm. Res. 2009, 32:383-389.
9. Jeong N.H., Woo M.K., Lee N.W., Hur S.J., Choi K.S., Kim H.J. Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade cervical intraepithelial neoplasia and cervical cancer. Arch. Pharm. Res. 2009, 32:1013-1018.
10. Jia M.W., Li Y.D. The relationship among gene expression, folding free energy and codon usage bias in Escherichia coli. FEBS Lett. 2005, 579:5333-5337.
11. Katz L., Burge C.B. Widespread selection for local RNA secondary structure in coding regions of bacterial genes. Genome Res. 2003, 13:2042-2051.
12. Kim H.J., Kim H.J. Glycosylation variant analysis of recombinant human tissue plasminogen activator produced in urea-cycle-enzyme-expressing Chinese hamster ovary (CHO) cell line. J. Biosci. Bioeng. 2006, 102:447-451.
13. Kim H.J., Kim S.Y., Lim S.J., Kim J.Y., Lee S.J., Kim H.J. One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr. Purif. 2010, 70:68-74.
14. Kim S.N., Jeong H.S., Park S.N., Kim H.J. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae. J. Virol. Methods 2007, 139:24-30.
15. Kofla G., Ruhnke M. Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression. J. Microbiol. Methods 2007, 68:178-183.
16. Kubo M., Imanaka T. mRNA secondary structure in an open reading frame reduces translation efficiency in Bacillus subtilis. J. Bacteriol. 1989, 171:4080-4082.
17. Kudla G., Murray A.W., Tollervey D., Plotkin J.B. Coding-sequence determinants of gene expression in Escherichia coli. Science 2009, 324:255-258.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. Madrid-Marina V., Torres-Poveda K., Lopez-Toledo G., Garcia-Carranca A. Advantages and disadvantages of current prophylactic vaccines against HPV. Arch. Med. Res. 2009, 40:471-477.
20. Malissard M., Zeng S., Berger E.G. The yeast expression system for recombinant glycosyltransferases. Glycoconj. J. 1999, 16:125-139.
21. Mossadegh N., Gissmann L., Muller M., Zentgraf H., Alonso A., Tomakidi P. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 2004, 326:57-66.
22. Muller M. Codon optimization of papillomavirus genes. Methods Mol. Med. 2005, 119:433-444.
23. Murphy G.M., Jia X.C., Yu A.C., Lee Y.L., Tinklenberg J.R., Eng L.F. Reverse transcription and polymerase chain reaction technique for quantification of mRNA in primary astrocyte cultures. J. Neurosci. Res. 1993, 35:643-651.
24. Palacios R.S., Roderfeld M., Hemmann S., Rath T., Atanasova S., Tschuschner A., Gressner O.A., Weiskirchen R., Graf J., Roeb E. Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab. Invest. 2008, 88:1192-1203.
25. Park M.A., Kim H.J., Kim H.J. Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr. Purif. 2008, 59:175-181.
26. Pinto L.A., Castle P.E., Roden R.B., Harro C.D., Lowy D.R., Schiller J.T., Wallace D., Williams M., Kopp W., Frazer I.H., Berzofsky J.A., Hildesheim A. HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine 2005, 23:3555-3564.
27. Schadlich L., Senger T., Kirschning C.J., Muller M., Gissmann L. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity. Vaccine 2009, 27:1511-1522.
28. Soni R., Carmichael J.P., Murray J.A. Parameters affecting lithium acetate-mediated transformation of Saccharomyces cerevisiae and development of a rapid and simplified procedure. Curr. Genet. 1993, 24:455-459.
29. Vladimirov N.V., Likhoshvai V.A., Matushkin Iu G. Correlation of codon biases and potential secondary structures with mRNA translation efficiency in unicellular organisms. Mol. Biol. (Mosk.) 2007, 41:926-933.
30. Wang X., Liu J., Zheng Y., Li J., Wang H., Zhou Y., Qi M., Yu H., Tang W., Zhao W.M. An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles. J. Biosci. Bioeng. 2008, 106:8-15.
31. Woese C.R. A nucleotide triplet code for amino acids. Biochem. Biophys. Res. Commun. 1961, 5:88-93.
32. Woo M.K., An J.M., Kim J.D., Park S.N., Kim H.J. Expression and purification of human papillomavirus 18 L1 virus-like particle from Saccharomyces cerevisiae. Arch. Pharm. Res. 2008, 31:205-209.